On February 21, 2024, Adverum Biotechnologies, Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.9 USD | +0.51% | -9.71% | +4.94% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.94% | 164M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.99% | 21.97B | |
-5.34% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- ADVM Stock
- News Adverum Biotechnologies, Inc.
- Adverum Biotechnologies, Inc. announced that it has received $127.5 million in funding from a group of investors